Veterinary Medicines

Valbazen 1,9 % 19 g/l Suspensie voor oraal gebruik

Not authorised
  • Albendazole
Download as PDF

Product identification

Medicine name:
Valbazen 1,9 % 19 g/l Suspensie voor oraal gebruik
Valbazen 1,9 % 19 g/l Suspension buvable
Valbazen 1,9 % 19 g/l Suspension zum Einnehmen
Active substance:
  • Albendazole
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    19.00
    gram(s)
    /
    1.00
    litre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Milk
        4
        day
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Valbazen 1,9 % 5 l Container Oral suspension
  • Valbazen 1,9 % 2.5 l Container Oral suspension
  • Valbazen 1,9 % 0.5 l Container Oral suspension
  • Valbazen 1,9 % 0.25 l Container Oral suspension
  • Valbazen 1,9 % 1 l Container Oral suspension

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Purna Pharmaceuticals N.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V134915
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 4/07/2022
Download
French (PDF)
Published on: 4/07/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 4/07/2022
Download
French (PDF)
Published on: 4/07/2022
Download
German (PDF)
Published on: 4/07/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."